Older adults living with HIV often carry a double burden: a lifelong, manageable infection plus financial strain, isolation, and stigma that can hit harder later in life. HIV is treatable and compatible with a near-normal lifespan. Staying on treatment, getting tested, and finding support protect both health and independence. This guide covers what to expect and where to start.

38,800
New diagnoses

in 2023

1.12 million
Living with HIV
~65%
Virally suppressed

≈723,000 — U=U

381,000
On PrEP
HIV in the US at a glance, 2023. Source: CDC AtlasPlus, 2023.
HIV in the US at a glance, 2023
ItemValue
New diagnoses38,800 — in 2023
Living with HIV1.12 million
Virally suppressed~65% — ≈723,000 — U=U
On PrEP381,000

What HIV is, and why aging with it is different

HIV is a virus that attacks the body's immune system, and it moves through three stages: an acute phase with a very high viral load, a long chronic phase (clinical latency) where the virus stays active but quiet, and AIDS, the most severe stage, defined by a CD4 count under 200 cells/mm³ or an opportunistic infection CDC. There's currently no cure, and once a person has HIV, they have it for life. But with treatment people live long, healthy lives and protect their partners StatPearls.

More people are now growing older with HIV because treatment works. An estimated 1.12 million people are living with HIV in the US, and about 38,800 were newly diagnosed in 2023 CDC AtlasPlus, 2023. A 20-year-old who starts treatment before their CD4 count falls below 200 now has a life expectancy approaching that of the general population Lancet HIV. That longevity is why early testing and treatment matter so much. It also means decades of medication costs, follow-up, and, for many, the emotional weight of a diagnosis that still carries stigma.

Symptoms — and the silent reality

Within 2 to 4 weeks after infection, about 90% of people develop flu-like symptoms — fever, chills, rash, night sweats, muscle aches, sore throat, fatigue, swollen lymph nodes, and mouth ulcers hiv.gov. This acute phase is when the viral load peaks above a million copies/mL and the virus is most contagious, so early symptoms after a risk warrant an urgent test rather than a wait.

Those symptoms look exactly like the flu, and some people have none at all. After the acute phase, HIV often causes years of no symptoms during clinical latency, which is why an older adult can carry it unknowingly until the immune system weakens. Symptoms can neither confirm nor rule out HIV; only a test can do that.

How HIV spreads

Only certain body fluids transmit HIV: blood, semen, vaginal fluid, rectal fluid, and breast milk CDC. The common routes are anal or vaginal sex, sharing needles or injection equipment, and from parent to child during pregnancy, childbirth, or breastfeeding. HIV does not spread through saliva or kissing, casual contact, surfaces, food, donating blood, insects, water, or air. It doesn't survive long outside the body.

That matters for older adults, who are sometimes assumed to be at low risk. Dating after a divorce or the loss of a spouse, new partners, and lower condom use after menopause all keep the risk real well into later life.

How HIV is tested

Testing is quick: a finger-stick or oral-swab rapid test gives results in minutes, or a lab draws blood. Tests are often free at health departments, and at-home kits exist — just mind the window period CDC. The USPSTF gives screening a Grade A recommendation: everyone ages 15 to 65 should be tested at least once, with repeat testing for anyone at increased risk USPSTF. There's no upper age cutoff that makes testing pointless.

A negative result only counts after the test's window has passed with no exposure during it. The window depends on the test:

Test typeDetects after exposure
Nucleic-acid test (NAT)10–33 days
Antigen/antibody (4th-gen) lab test18–45 days
Antibody / rapid tests23–90 days

If you're unsure how soon to test, our guide on when to test after exposure walks through the timing, and you can get tested or compare testing providers to find an option that fits. For the full picture on retesting and windows, see hiv testing.

Treatment

Everyone with HIV should take antiretroviral therapy (ART) and start as soon as possible after diagnosis CDC. ART is a combination of HIV medicines — drug classes include integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors — and many people take a single daily pill. It's lifelong, and the goal is an undetectable viral load, which most people reach within 6 months of starting.

An undetectable viral load controls HIV but doesn't eradicate it: latent reservoirs persist in cells and tissues, and the virus rebounds if treatment stops HHS. The handful of people in long-term remission after stem-cell transplants — the Berlin patient, the London patient, and a New York woman documented in 2022 — had those transplants to treat cancer, using rare HIV-resistant donor cells; the procedure is high-risk and not a scalable cure NIH, 2022. A cure remains a research goal, not an option you can ask for. For regimens and what daily treatment involves, see hiv treatment.

For older couples, U=U matters: a person who takes HIV medicine as prescribed and stays undetectable will not transmit HIV to sex partners. Across the PARTNER, Opposites Attract, and PARTNER2 studies — more than 125,000 condomless sex acts — there were zero linked transmissions while the partner was virally suppressed PARTNER, Lancet. Treatment protects both the person and their partner CDC.

Complications if HIV is left untreated

Untreated HIV progresses to AIDS — a CD4 count under 200 or an opportunistic infection (an infection that takes hold because the immune system is too weakened to fight it). This is the most severe stage and can develop after years of silent clinical latency. For older adults, a weakened immune system compounds the other conditions of aging, one more reason starting ART early protects long-term independence.

Prevention

The CDC's core prevention tools are condoms, PrEP, PEP, treatment-as-prevention (U=U), and regular testing CDC. PrEP is for people without HIV who are exposed through sex or injection drug use, and it cuts HIV risk from sex by about 99% when taken as prescribed.

  • Daily oral PrEP options are Truvada and Descovy; a long-acting injectable, cabotegravir (Apretude), is given as two doses a month apart, then every 2 months.
  • Descovy is not approved for people at risk through receptive vaginal sex or for people who inject drugs — Truvada is approved for all those routes.
  • PrEP requires a confirmed HIV-negative test before starting and at follow-up visits, plus baseline kidney-function, hepatitis B, and STI screening, because starting PrEP with undiagnosed HIV risks drug resistance.
  • Newer twice-yearly injectable lenacapavir produced zero infections among women in the PURPOSE 1 trial, the strongest HIV-prevention result yet WHO.

If you might have just been exposed, PEP can prevent infection but must start within 72 hours of exposure and is taken daily for 28 days CDC. That's an urgent-care or ER conversation, not a wait-and-test one — PEP cut HIV seroconversion by about 81% in the original study. It's for emergencies only and is not a substitute for PrEP or condoms.

When to see a clinician

See a clinician promptly if you've had a possible exposure in the last 72 hours (ask about PEP that same day), if you develop flu-like symptoms after a sexual or injection risk, or simply if you've never been tested. Older adults who are dating again should ask for HIV screening directly, since it isn't always offered. If you're navigating telling a partner, our piece on the ethics of hiv disclosure may help.